Our commitment to excellence is demonstrated through international certifications, including ISO 9001:2015, 14001:2015, and 45001:2018. In addition, our facility is approved by the Ministry of Health in Oman, reinforcing our dedication to globally recognized standards. We operate under stringent quality assurance and control systems that meet cGMP standards and Pakistan's Drugs Act of 1976, ensuring that every product adheres to the strictest safety and efficacy requirements.
If you experience any issues with our products—such as defects, damage, or discrepancies from specifications—we encourage you to report them through the contact channels below. Your report helps us maintain the highest level of quality across our product range. We ensure that all inquiries are documented and appropriately processed. Any personal data you provide will be handled in strict accordance with our Privacy Standards, ensuring full respect for your privacy. If you wish to edit or delete any Personal Health Information (PHI) previously shared with us, please contact us at info@searlepakistan.com or via the phone numbers listed above. Our commitment to quality extends beyond compliance; it’s about safeguarding lives and continuously improving the safety of our products to better serve our patients.
The Searle Company Limited is committed to improving patient care and safety, ensuring public health concerning the use of medicines, and promoting understanding, training, and effective communication among healthcare professionals and the public.
Any medicine, no matter how safe and effective, can sometimes cause side effects. We take our obligation to report product safety information to health authorities very seriously, and all of us at Searle share the responsibility for improving the lives of patients and meeting regulatory obligations to forward safety information concerning Searle products.
What needs to be reported?
All medicines have risks as well as benefits, and the Pharmacovigilance department plays an important role by continuously evaluating information received from patients, healthcare professionals, and members of the public to balance benefits against risks.
Some of the information collected includes:
If you think you have experienced a side effect or unexpected reaction from a Searle medicine, speak to the healthcare professional who prescribed the medicine or contact your pharmacist as soon as you can. To enable us to continuously monitor the safety of Searle products, report immediately or within 24 hours to Searle Pharmacovigilance Department at +92 21 371 70 200-201 or by email pv@searlecompany.com.
For Quality related complaints of SEARLE
pharma product/device that is damaged, defective, or not as per defined
specification, download the form and post or email on given
contact details
Searle Pharmacovigilance Department
The Searle Company Ltd, Pakistan, One IBL
Centre, 2nd Floor, Plot# 1, Block 7 & 8, DMCS, Tipu Sultan Road, Off.
Shahrah-e-Faisal, Karachi, Pakistan.
Phone: +92 21 371 70 200-201
Fax: +92 21 371 70 224-225
For Queries E-mail: info@searlecompany.com
Disclaimer: We treat all your “personal data” under the local data protection
rule. Any personal data provided here related to adverse events or other
activities related to pharmacovigilance will be used solely for this purpose.